Dramatic Response of Pulmonary Sarcomatoid Carcinoma to Nivolumab Combined with Anlotinib: A Case Report

Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non-small-cell lung cancer, which is resistant to the conventional chemotherapy and radiotherapy with a poor prognosis. Limited case reports have showed good response to the immunotherapy in PSC patients with high PD-L1 expression generally....

Full description

Bibliographic Details

Published in:	Case Reports in Oncology
Main Authors:	Caibao Jin, Bin Yang
Format:	Article
Language:	English
Published:	Karger Publishers 2020-06-01
Subjects:	anlotinib immunotherapy nivolumab pulmonary sarcomatoid carcinoma pd-l1
Online Access:	https://www.karger.com/Article/FullText/507568